Cargando…
Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control
BACKGROUND: The seven-valent pneumococcal conjugate vaccine (PCV) was introduced in England in September 2006, changing to the 13-valent vaccine in April 2010. PCV impact on invasive pneumococcal disease (IPD) has been extensively reported, but less described is its impact on the burden of pneumonia...
Autores principales: | Thorrington, Dominic, Andrews, Nick, Stowe, Julia, Miller, Elizabeth, van Hoek, Albert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804014/ https://www.ncbi.nlm.nih.gov/pubmed/29415741 http://dx.doi.org/10.1186/s12916-018-1004-z |
Ejemplares similares
-
Pneumococcal Conjugate Vaccines and Otitis Media
por: Taylor, Sylvia, et al.
Publicado: (2012) -
Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials
por: Fletcher, Mark A., et al.
Publicado: (2012) -
Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review
por: Taylor, Sylvia, et al.
Publicado: (2012) -
Erratum to “Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials”
por: Fletcher, Mark A., et al.
Publicado: (2012) -
Pneumococcal Otitis Media by Contagion
Publicado: (1909)